NLRP3 and familial Mediterranean fever: In the current study, for the first time, we evaluated the anti-inflammatory effects of DMAPT, as an SM inhibitor, on the NLRP3-dependent pathway affecting LPS/ATP-stimulated PBMCs of FMF patients.